| Brandi Frazier, | |
|
1309 S Cannon Blvd, Kannapolis, NC 28083-6232 | |
| (704) 933-3212 | |
| Not Available |
| Full Name | Brandi Frazier |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1309 S Cannon Blvd, Kannapolis, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316493539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 75640 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brandi Frazier, 284 Executive Park Dr., Suite 100, Concord, NC 28025-1894 Ph: (704) 939-1100 | Brandi Frazier, 1309 S Cannon Blvd, Kannapolis, NC 28083-6232 Ph: (704) 933-3212 |
News Archive
Combining substance abuse treatment with regular medical care can successfully treat people with opioid or alcohol addiction, providing an option that might expand treatment and lower the cost of caring for people caught up in the nation's opioid epidemic, according to a new RAND Corporation study.
The Society for Cardiovascular Angiography and Interventions (SCAI) today issued a position statement on the performance of percutaneous coronary intervention (PCI) in ambulatory surgical centers (ASCs). The document was published in SCAI's official journal, Catheterization and Cardiovascular Interventions.
Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest, neck or head had significantly reduced risk of suffering a stroke, and possibly other cardiovascular complications, according to new research in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.
Symbiomix Therapeutics, a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women's health infections, today announced results from its Phase 1 clinical program demonstrating that its lead product candidate, SYM-1219, was safe and well tolerated and had predictable pharmacokinetics (PK), and that contraceptive efficacy for birth control pills would not be altered by SYM-1219 administration.
Yale scientists have discovered the molecular pathway by which maternally inherited deafness appears to occur: Mitochondrial DNA mutations trigger a signaling cascade, resulting in programmed cell death.
› Verified 2 days ago
Debra Butler, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1309 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-933-3212 Fax: 704-933-3221 | |
Mrs. Ann Beaver Ware, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1706 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-933-3212 | |
Linda Ward Kellogg, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1305 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-939-1100 | |
Pamela Sue Corson, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1309 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-933-3212 Fax: 704-933-3221 | |
Dion Harris, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1309 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-933-3212 Fax: 704-933-3221 | |
Darlene Kay Gilmore, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1305 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-939-1100 |